Tekoriutė Paulina, Matuliauskaitė Monika, Jonaitis Laimas Virginijus
Faculty of Medicine, Lithuanian University of Health Sciences.
Department of Gastroenterology, Lithuanian University of Health Sciences.
Acta Med Litu. 2021;28(2):355-359. doi: 10.15388/Amed.2021.28.2.14. Epub 2021 Aug 11.
5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation of the drug the renal function usually restores. However, if damage has not been detected for a long time, irreversible changes may occur. In this article, we present a clinical case of mesalamine induced IN. A 56-year-old man who has had ulcerative colitis for 20 years, was admitted due to mesalamine induced acute renal failure. A year before, the patient had been diagnosed with mesalamine-induced interstitial nephritis and the treatment with mesalamine was discontinued. The symptoms of ulcerative colitis worsened, and the patient independently decided to start taking mesalamine, which resulted in worsening of his health condition and impaired renal function. Mesalamine has been discontinued, additional treatment for acute kidney failure has been administered including hemodialysis. Renal function recovered and the patient was released for further treatment of ulcerative colitis and monitoring of renal function.
5-氨基水杨酸(5-ASA)制剂广泛用于治疗炎症性肠病。最常用的药物是美沙拉嗪。总体而言,它是一种非常安全的药物,副作用很少。这种药物的一种罕见副作用是间质性肾炎(IN)。停药后肾功能通常会恢复。然而,如果长时间未检测到损伤,可能会发生不可逆的变化。在本文中,我们介绍一例美沙拉嗪诱发IN的临床病例。一名患有溃疡性结肠炎20年的56岁男性因美沙拉嗪诱发急性肾衰竭入院。一年前,该患者被诊断为美沙拉嗪诱发的间质性肾炎,停用了美沙拉嗪。溃疡性结肠炎症状恶化,患者自行决定重新开始服用美沙拉嗪,这导致其健康状况恶化和肾功能受损。已停用美沙拉嗪,并对急性肾衰竭进行了包括血液透析在内的额外治疗。肾功能恢复,患者出院,继续接受溃疡性结肠炎治疗并监测肾功能。